These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 10709100)

  • 1. Epigenetic silencing of maspin gene expression in human breast cancers.
    Domann FE; Rice JC; Hendrix MJ; Futscher BW
    Int J Cancer; 2000 Mar; 85(6):805-10. PubMed ID: 10709100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of the maspin gene by promoter hypermethylation in thyroid cancer.
    Boltze C; Schneider-Stock R; Quednow C; Hinze R; Mawrin C; Hribaschek A; Roessner A; Hoang-Vu C
    Int J Mol Med; 2003 Oct; 12(4):479-84. PubMed ID: 12964023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer.
    Maass N; Biallek M; Rösel F; Schem C; Ohike N; Zhang M; Jonat W; Nagasaki K
    Biochem Biophys Res Commun; 2002 Sep; 297(1):125-8. PubMed ID: 12220518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic regulation of maspin expression in human ovarian carcinoma cells.
    Rose SL; Fitzgerald MP; White NO; Hitchler MJ; Futscher BW; De Geest K; Domann FE
    Gynecol Oncol; 2006 Aug; 102(2):319-24. PubMed ID: 16457875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of cell-type-specific methylation at the Maspin gene promoter is frequently involved in undifferentiated thyroid cancers.
    Ogasawara S; Maesawa C; Yamamoto M; Akiyama Y; Wada K; Fujisawa K; Higuchi T; Tomisawa Y; Sato N; Endo S; Saito K; Masuda T
    Oncogene; 2004 Feb; 23(5):1117-24. PubMed ID: 14743202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation.
    Wu Y; Alvarez M; Slamon DJ; Koeffler P; Vadgama JV
    BMC Cancer; 2010 Feb; 10():32. PubMed ID: 20132554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutant p53 and aberrant cytosine methylation cooperate to silence gene expression.
    Oshiro MM; Watts GS; Wozniak RJ; Junk DJ; Munoz-Rodriguez JL; Domann FE; Futscher BW
    Oncogene; 2003 Jun; 22(23):3624-34. PubMed ID: 12789271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant methylation of the maspin promoter is an early event in human breast cancer.
    Futscher BW; O'Meara MM; Kim CJ; Rennels MA; Lu D; Gruman LM; Seftor RE; Hendrix MJ; Domann FE
    Neoplasia; 2004; 6(4):380-9. PubMed ID: 15256060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of demethylating agent 5-aza-2(')-deoxycytidine and histone deacetylase inhibitor FR901228 on maspin gene expression in oral cancer cell lines.
    Murakami J; Asaumi J; Maki Y; Tsujigiwa H; Kuroda M; Nagai N; Yanagi Y; Inoue T; Kawasaki S; Tanaka N; Matsubara N; Kishi K
    Oral Oncol; 2004 Jul; 40(6):597-603. PubMed ID: 15063388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression of the maspin gene associated with epigenetic modification in melanoma cells.
    Wada K; Maesawa C; Akasaka T; Masuda T
    J Invest Dermatol; 2004 Mar; 122(3):805-11. PubMed ID: 15086568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MnSOD up-regulates maspin tumor suppressor gene expression in human breast and prostate cancer cells.
    Duan H; Zhang HJ; Yang JQ; Oberley LW; Futscher BW; Domann FE
    Antioxid Redox Signal; 2003 Oct; 5(5):677-88. PubMed ID: 14580325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human pancreatic carcinoma cells activate maspin expression through loss of epigenetic control.
    Fitzgerald M; Oshiro M; Holtan N; Krager K; Cullen JJ; Futscher BW; Domann FE
    Neoplasia; 2003; 5(5):427-36. PubMed ID: 14670180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells.
    Akiyama Y; Maesawa C; Ogasawara S; Terashima M; Masuda T
    Am J Pathol; 2003 Nov; 163(5):1911-9. PubMed ID: 14578190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-expression and epigenetic modification of maspin induced apoptosis in MCF-7 cells mediated by myocardin.
    Liao XH; Li YQ; Wang N; Zheng L; Xing WJ; Zhao DW; Yan TB; Wang Y; Liu LY; Sun XG; Hu P; Zhou H; Zhang TC
    Cell Signal; 2014 Jun; 26(6):1335-46. PubMed ID: 24607789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and regulation of tumor suppressor gene maspin in breast cancer.
    Maass N; Nagasaki K; Ziebart M; Mundhenke C; Jonat W
    Clin Breast Cancer; 2002 Oct; 3(4):281-7. PubMed ID: 12425757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic antineoplastic action of DNA methylation inhibitor 5-AZA-2'-deoxycytidine and histone deacetylase inhibitor depsipeptide on human breast carcinoma cells.
    Primeau M; Gagnon J; Momparler RL
    Int J Cancer; 2003 Jan; 103(2):177-84. PubMed ID: 12455031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reprogramming epigenetic silencing: artificial transcription factors synergize with chromatin remodeling drugs to reactivate the tumor suppressor mammary serine protease inhibitor.
    Beltran AS; Sun X; Lizardi PM; Blancafort P
    Mol Cancer Ther; 2008 May; 7(5):1080-90. PubMed ID: 18483297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells.
    Rice JC; Massey-Brown KS; Futscher BW
    Oncogene; 1998 Oct; 17(14):1807-12. PubMed ID: 9778046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of maspin expression is associated with development and progression of gastric carcinoma with p53 abnormality.
    Ito R; Nakayama H; Yoshida K; Oda N; Yasui W
    Oncol Rep; 2004 Nov; 12(5):985-90. PubMed ID: 15492782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.